1. Neonatal epidermolysis bullosa: a clinical practice guideline.
- Author
-
Saad R, Duipmans J, Yerlett N, Plevey K, McCuaig C, Woolfe W, Steinau K, Phillips J, Azzopardi N, Thompson K, Ferreira da Rocha AC, Torres-Pradilla M, Ott H, Patton D, Moore Z, Murphy P, and Mayre-Chilton K
- Subjects
- Humans, Infant, Newborn, Parents, Patient Discharge standards, Patient Care Team organization & administration, Epidermolysis Bullosa therapy, Epidermolysis Bullosa diagnosis
- Abstract
DEBRA International is undertaking a long-term initiative to develop clinical practice guidelines (CPGs) for epidermolysis bullosa (EB), to -improve the clinical care of people living with EB. Current neonatal care is based on evidence, clinical expertise and trial and error, with collaboration between the EB specialist team, parent or carer and patient, and is dependent on the neonate's individual presentation and type of EB. Early intervention based on research and clinical practice is needed to establish a foundation of knowledge to guide international practitioners to create and improve standards of care and to be able to work effectively with those newly diagnosed with EB. This CPG was created by an international panel with expertise working with persons with EB. The CPG focuses on neonatal care using a systematic review methodology covering four key areas: (i) diagnosis and parental psychosocial support; (ii) hospital management: medical monitoring, wound care and pain; (iii) feeding and nutrition; and (iv) discharge planning and EB education. These four areas highlight the importance of a multidisciplinary team approach, to provide a patient-specific holistic care model that incorporates the needs and wishes of the parents and carers. The Hospital Implementation Tool included promotes transfer of theory to clinical practice., Competing Interests: Conflicts of interest With one exception (K.M.-C.), this panel of researchers claims no financial conflicts of interest. K.M.-C. declared a potential conflict from her professional work coordinating guideline development for DEBRA International between 1 February 2016 and 6 February 2023. This author was therefore not involved in the final editions of the recommendations after review panel feedback. All other panel members and reviewers self-declared no potential conflicts of interest with respect to the publication of this guideline., (© The Author(s) 2024. Published by Oxford University Press on behalf of British Association of Dermatologists.)
- Published
- 2024
- Full Text
- View/download PDF